Feng Chi Biotech Corp. (TPEX:6744)

Feng Chi Biotech Revenue

In the year 2025, Feng Chi Biotech had annual revenue of 177.36M TWD with 3.66% growth. Feng Chi Biotech had revenue of 81.32M in the half year ending December 31, 2025, a decrease of -5.69%.

• Revenue: 177.36M
• Revenue Growth: +3.66%
• P/S Ratio: 1.45
• Revenue / Employee: n/a
• Employees: 32
• Market Cap: 257.18M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	177.36M	6.26M	3.66%
Dec 31, 2024	171.10M	-9.48M	-5.25%
Dec 31, 2023	180.58M	-12.88M	-6.66%
Dec 31, 2022	193.46M	10.89M	5.96%
Dec 31, 2021	182.57M	3.66M	2.05%